Your browser doesn't support javascript.
loading
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022.
Stoliaroff-Pepin, Anna; Peine, Caroline; Herath, Tim; Lachmann, Johannes; Perriat, Delphine; Dörre, Achim; Nitsche, Andreas; Michel, Janine; Grossegesse, Marica; Hofmann, Natalie; Rinner, Thomas; Kohl, Claudia; Brinkmann, Annika; Meyer, Tanja; Dorner, Brigitte G; Stern, Daniel; Treindl, Fridolin; Hein, Sascha; Werel, Laura; Hildt, Eberhard; Gläser, Sven; Schühlen, Helmut; Isner, Caroline; Peric, Alexander; Ghouzi, Ammar; Reichardt, Annette; Janneck, Matthias; Lock, Guntram; Schaade, Lars; Wichmann, Ole; Harder, Thomas.
Afiliação
  • Stoliaroff-Pepin A; Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Germany. Electronic address: Stoliaroff-PepinA@rki.de.
  • Peine C; Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Germany. Electronic address: PeineC@rki.de.
  • Herath T; Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Germany.
  • Lachmann J; Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Germany.
  • Perriat D; Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Germany.
  • Dörre A; Department for Infectious Disease Epidemiology, Robert Koch Institute, Germany.
  • Nitsche A; Centre for Biological Threats and Special Pathogens, ZBS1 Highly Pathogenic Viruses, Robert Koch Institute, Germany.
  • Michel J; Centre for Biological Threats and Special Pathogens, ZBS1 Highly Pathogenic Viruses, Robert Koch Institute, Germany.
  • Grossegesse M; Centre for Biological Threats and Special Pathogens, ZBS1 Highly Pathogenic Viruses, Robert Koch Institute, Germany.
  • Hofmann N; Centre for Biological Threats and Special Pathogens, ZBS1 Highly Pathogenic Viruses, Robert Koch Institute, Germany.
  • Rinner T; Centre for Biological Threats and Special Pathogens, ZBS1 Highly Pathogenic Viruses, Robert Koch Institute, Germany.
  • Kohl C; Centre for Biological Threats and Special Pathogens, ZBS1 Highly Pathogenic Viruses, Robert Koch Institute, Germany.
  • Brinkmann A; Centre for Biological Threats and Special Pathogens, ZBS1 Highly Pathogenic Viruses, Robert Koch Institute, Germany.
  • Meyer T; Centre for Biological Threats and Special Pathogens, ZBS3 Biological Toxins, Robert Koch Institute, Germany.
  • Dorner BG; Centre for Biological Threats and Special Pathogens, ZBS3 Biological Toxins, Robert Koch Institute, Germany.
  • Stern D; Centre for Biological Threats and Special Pathogens, ZBS3 Biological Toxins, Robert Koch Institute, Germany.
  • Treindl F; Centre for Biological Threats and Special Pathogens, ZBS3 Biological Toxins, Robert Koch Institute, Germany.
  • Hein S; Division Virology, Paul-Ehrlich-Institute, Germany.
  • Werel L; Division Virology, Paul-Ehrlich-Institute, Germany.
  • Hildt E; Division Virology, Paul-Ehrlich-Institute, Germany.
  • Gläser S; Klinik für Innere Medizin - Pneumologie und Infektiologie, Vivantes Klinikum Neukölln und Spandau, Berlin, Germany.
  • Schühlen H; Vivantes Netzwerk für Gesundheit GmbH, Direktorat Klinische Forschung & Akademische Lehre, Berlin, Germany.
  • Isner C; Klinik für Innere Medizin - Infektiologie, Vivantes Auguste-Viktoria-Klinikum, Rubensstr. 125, 12157 Berlin, Germany.
  • Peric A; Klinik für Pneumologie und Infektiologie, Vivantes Klinikum im Friedrichshain, Landsberger Allee 49, 10249 Berlin, Germany.
  • Ghouzi A; Schön Klinik Düsseldorf, Interdisziplinäre Notaufnahme, Am Heerdter Krankenhaus 2, 40549 Düsseldorf, Germany.
  • Reichardt A; Helios Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125 Berlin, Germany.
  • Janneck M; Klinik für Kardiologie, Sektion Nephrologie, Albertinen Krankenhaus, Süntelstraße 11a, 22457 Hamburg, Germany.
  • Lock G; Klinik für Innere Medizin, Albertinen Krankenhaus, Süntelstraße 11a, 22457 Hamburg, Germany.
  • Schaade L; Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Germany.
  • Wichmann O; Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Germany.
  • Harder T; Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Germany.
Vaccine ; 41(2): 290-293, 2023 01 09.
Article em En | MEDLINE | ID: mdl-36509640
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article